Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway

Interventional study with minimal risks and constraints, with evaluation of the incidence of lung cancers by low-dose thoracic CT scan without injection of contrast medium, of the immunological, inflammatory and metabolic blood profile and of the microbiota; systematic proposal of smoking cessation for active smokers or assistance in maintaining cessation.

NCT Number	NCT06387017
Lead Sponsor	Assistance Publique Hopitaux De Marseille
Conditions	Smoking-related Pathology, Atheroma, Non-progressive Cancer > 5 Years, Lung Cancer
Enrollment	750 participants
Start Date	2024-04-02
Primary Completion	2028-07 (estimated)
Study Completion	2029-07 (estimated)
Updated on ClinicalTrials.gov	2024-04-26